City

Geneva (1)

New York (1)

Pierre-benite (1)

Condition

Immunosuppressed (3)

Healthy (2)

Asthmatic (1)

Breakthrough Infection (1)

Covid-19 (1)

Immunocompromised (1)

Neuromuscular Diseases (1)

SARS-COV-2 (1)

SARS-COV-2 Infection (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

n/a (1)

Sponsor

Hospices Civils de Lyon (1)

Pfizer (1)

University Hospital, Geneva (1)

Collaborator

Intervention

bnt162b2 (tozinameran) (1)

tuberculin antigen (1)

Study Documents

Intervention Type

biological (2)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

Immunosuppressed

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID-19 Vaccination and Breakthrough Infections Among Persons

Completed

Immunocompromised
+5 more

BNT162b2 (Tozinameran)

New York, New York

Pfizer Inc.

Jul 1, 2022

Clinical Presentation of H1N1 Infection in Children in Geneva

Completed

Healthy
+3 more

Geneva, GE, Switzerland

Children's Hospital of Geneva, HUG

Dec 10, 2012

Healthy, Immunosuppressed Trial in Pierre-benite (Tuberculin antigen)

Terminated

Healthy
Immunosuppressed

Tuberculin antigen

Pierre-benite, France

Centre Hospitalier Lyon Sud

Dec 22, 2010